ES
MARKETS / NYSE / DOC
NYSE · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP

Healthpeak Properties, Inc. DOC

19 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$604.0M
▲ 6.2% vs FY2024
Dividend streak
1 yrs
Raised every year since 2025
EPS · FY25
$0.10
Dividend / sh · FY25
$1.22
Payout · FY25
1190%
ROE · FY25
0.9%
Net margin · FY25
11.8%
Dividend coverage
0.1×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 604.0M
Revenue, FY2025 · full 19-year series below
Revenue Net income
0.81.62.40.60.12007201020132016201920222025
0.81.62.40.60.12016201920222025

12 cents of every revenue dollar became profit this year.

Per share
USD 0.10
Diluted EPS, FY2025
EPS Dividend
1231.220.102007201020132016201920222025
1231.220.102016201920222025

Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.

Profitability
0.9%
Return on equity, FY2025
ROE
51015200.9%2007201020132016201920222025
51015200.9%2016201920222025
Operating margin—
Net margin11.8%
Return on assets0.4%

Each USD of equity produced 1 cents of profit this year.

Returned to shareholders
USD 946.2M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 849.1M
Net buybacksUSD 97.1M
Share of profit1326.3%
Consecutive raises1 years

USD 849.1M in dividends and USD 97.1M in buybacks — 1326% of the year's profit, so the payout drew on cash built up earlier.

Growth
+6.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+6.9%
+6.7%
−11.0%
−4.7%
Net income
−47.8%
−29.6%
−9.7%
EPS, diluted
−52.3%
−33.5%
−14.2%
Dividend / share
+0.6%
−3.8%
−6.0%
−2.8%
Returned to shareholders
+9.7%
+3.5%
−1.0%
+3.2%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.70B
Shares outstanding, FY2025
0.250.702007201020132016201920222025
0.470.702016201920222025
Change, 5 years+29.1%
Change, 10 years+49.3%

The share count grew 29% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 20.3B
total assets, end of FY2025
Total assetsUSD 20.3B
EquityUSD 7.5B
CashUSD 467.5M
Gross debtUSD 9.8B
Net debtUSD 9.4B

Net debt stands at 125% of equity.

History
19 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
0.6
0.6
0.5
0.5
0.5
0.4
0.1
0.1
0.5
2.1
1.9
1.6
2.1
1.9
1.7
1.2
1.1
1.1
1.0
Operating income $B
·
·
·
·
·
·
−0.0
−0.0
0.0
0.0
0.0
−0.0
·
·
·
·
·
·
·
EBITDA $B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Income tax $B
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.1
0.2
0.3
0.5
0.5
0.4
0.0
1.1
0.4
0.6
−0.6
0.9
1.0
0.8
0.5
0.3
0.1
0.4
0.6
EPS, diluted $
0.10
0.36
0.56
0.92
0.93
0.77
0.09
2.24
0.88
1.34
−1.21
2.00
2.13
1.90
1.29
1.00
0.40
1.79
2.70
Dividend / sh $
1.22
1.20
1.20
1.20
1.20
1.48
1.48
1.48
1.48
2.10
2.26
2.18
2.10
2.00
1.92
1.86
1.84
1.82
1.78
Payout %
1190
327
215
129
129
190
1582
66
168
156
−187
109
99
104
146
179
393
102
64
ROE %
0.9
3.3
4.7
7.6
7.6
6.5
0.8
18.9
7.6
8.4
−5.6
8.6
9.1
8.5
6.3
4.8
2.4
8.6
·
Shares out B
0.70
0.70
0.55
0.55
0.54
0.54
0.51
0.48
0.47
0.47
0.47
0.46
0.46
0.45
0.41
0.37
0.29
0.25
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
37 of 37
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed